Caixin
Caixin Global – Latest China News & Headlines

Home >

ABOUT US

CX Tech is Caixin Global's real-time tech news portal, featuring 24-hour news, short-form analysis, and roundups from business and tech media in China.

TRENDING
Hikvision Foresees Overseas Customer Losses Amid U.S. Blacklisting
As Investors Circle Milk Tea-Makers, Experts Warn of Coming Bubble
China Online Retail Sales Growth Slows but Stays in Double-Digits
LATEST
Chinese Fintech Firm 51 Credit Card Raided by Police
China Net Execs Tout ‘Industrial Web’ at World Internet Conference
China Online Retail Sales Growth Slows but Stays in Double-Digits
As Investors Circle Milk Tea-Makers, Experts Warn of Coming Bubble
Hikvision Foresees Overseas Customer Losses Amid U.S. Blacklisting
Tencent-Backed E-Book Platform Partners With Disney for ‘Star Wars’ Project
iQiyi Looks to AI to Force-Feed Ads to Viewers
Popular Walking App Accused of Financial Fraud
WeWork Putting the Brakes on China Push: Report
‘No New Progress’ on Zotye Joint-Venture With Ford
Qutoutiao’s Online Literature Unit Gets $100 Million Windfall
NBA’s China Crisis Has Already Caused ‘Substantial’ Losses, Commissioner Says
Northern China Aims to Curb Toxic Air Pollution by 4% This Winter
China’s Economic Growth Dips to New Nearly Three-Decade Low
Tesla’s China Plant Is Hooked Up to State Grid Power Supply
Didi Pushes Further Into Latin America With Eye on Costa Rica
Homeowners Demand Refunds After Developer Cuts Prices
Controversial WeChat Public Account Operator Eyes High-Tech Board IPO
Burgeoning Online Marketplace in Crisis After Luring New Shoppers With Merchants’ Money
Huawei Posts Strong Revenue Growth Despite U.S. Export Ban
Chinese Genomics Giant BGI Wages Patent War Against Illumina

By Wang Luyao and Han Wei / May 30, 2019 03:24 AM / Business & Tech

Photo: IC Photo

Photo: IC Photo

A unit of China’s leading genetic testing company BGI Group filed a patent infringement case against U.S. genomics giant Illumina Inc. in an escalation of patent disputes surrounding key DNA sequencing technologies.

BGI’s gene sequencing manufacturing subsidiary MGI Tech Co. said Wednesday that its U.S.-based unit Complete Genomics filed the case in Delaware demanding that Illumina immediately stop selling several sequencing products and related sequencing chemistry reagents that allegedly violate BGI patents.

The latest development reflected a heated patent battle between the two genomics companies. Illumina filed two lawsuits in March and May in Europe accusing BGI of patent infringement.

In a statement to Caixin last week, BGI said it “will take corresponding legal actions” to deal with the legal disputes with Illumina and “will not rule out the use of legal weapons such as counterclaims to protect its legal rights.”

In a letter to Caixin, Illumina called the BGI's claims “meritless” and said it "fully expects to succeed in the litigation".

Share this article
Open WeChat and scan the QR code